Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Summary
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
Delayed Swiss Exchange  -  11:31 2022-07-06 am EDT
548.20 CHF   +3.51%
07/01Lonza Group Announces Management Changes, Effective August 1, 2022
CI
07/01Lonza Group Investing $522 Million to Construct Drug Product Fill and Finish Facility in Switzerland
MT
07/01Lonza Names Maria Soler Nunez as Head of Group Operations
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about LONZA GROUP AG
07/01Lonza Group Announces Management Changes, Effective August 1, 2022
CI
07/01Lonza Group Investing $522 Million to Construct Drug Product Fill and Finish Facility i..
MT
07/01Lonza Names Maria Soler Nunez as Head of Group Operations
DJ
07/01Maria Soler Nunez appointed as Head, Group Operations
EQ
07/01Lonza To Develop $523 Million Drug Product Fill, Finish Facility In Switzerland
MT
07/01Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein..
EQ
07/01Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein..
CI
06/26Lonza Signs License Deal With Adva Biotechnology For Automated Bioreactor-linked Patent..
MT
06/24LONZA : and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bior..
PU
06/15Lonza Group Signs Manufacturing Agreement With Pierre Fabre
MT
06/08Lonza Rolls Out PyroCell Monocyte Activation Test System For In Vitro Testing
MT
06/07LONZA : More Sensitive Non-endotoxin Pyrogen Detection Now Possible with Lonza's New PyroC..
PU
06/03AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
06/01Lonza Delivers Early Phase Clinical Manufacturing Facility in US
MT
06/01LONZA : Completes Dedicated Early Clinical Phase Development and Manufacturing Facility in..
PU
More most relevant news
All news about LONZA GROUP AG
07/01Lonza Group Announces Management Changes, Effective August 1, 2022
CI
07/01Lonza Group Investing $522 Million to Construct Drug Product Fill and Finish Facility i..
MT
07/01Lonza Names Maria Soler Nunez as Head of Group Operations
DJ
07/01Maria Soler Nunez appointed as Head, Group Operations
EQ
07/01Lonza To Develop $523 Million Drug Product Fill, Finish Facility In Switzerland
MT
07/01Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein..
EQ
07/01Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein..
CI
06/26Lonza Signs License Deal With Adva Biotechnology For Automated Bioreactor-linked Patent..
MT
06/24LONZA : and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bior..
PU
06/15Lonza Group Signs Manufacturing Agreement With Pierre Fabre
MT
More news
News in other languages on LONZA GROUP AG
11:52aAktien Schweiz erholt - Franken zum Euro immer fester
07/05Aktien Schweiz schwach - Rezessionsangst sorgt für Verkäufe
07/05OPINIONES DE LOS ANALISTAS DEL DÍA : BEA Systems, Intesa Sanpaolo, InBev, Prosus, Lonza, M..
07/05BOLSA DE MADRID : ¿El regreso del duty free?
07/05Le retour du duty free ?
07/05AVIS D'ANALYSTES DU JOUR : Crédit Agricole, Pernod Ricard, BNP, Rémy Cointreau, Lonza, Mon..
07/01Aktien Schweiz stabilisieren sich
07/01Lonza injecte un demi-milliard dans des installations à Stein
07/01Lonza Group annonce des changements au niveau de la direction, à compter du 1er août 20..
07/01BOLSA DE MADRID : Esta vez no es diferente
More news
Analyst Recommendations on LONZA GROUP AG
06/03AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
04/21AlphaValue/Baader Europe Lifts Price Target on Lonza Group
MT
02/28AlphaValue/Baader Europe Lifts Price Target on Lonza Group
MT
01/28AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
01/25AlphaValue/Baader Europe Lowers Price Target on Lonza Group, Upgrades Recommendation to..
MT
More recommendations
Press releases
07/01Maria Soler Nunez appointed as Head, Group Operations
EQ
07/01Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein..
EQ
06/24LONZA : and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bior..
PU
06/07LONZA : More Sensitive Non-endotoxin Pyrogen Detection Now Possible with Lonza's New PyroC..
PU
06/01LONZA : Completes Dedicated Early Clinical Phase Development and Manufacturing Facility in..
PU
More press releases
Analysis
EuroAPI gains on market debut after spin-off from Sanofi
Official Publications
05/05Dividends 
05/05Dividends 
05/05Proxy Statments 
05/05Proxy Statments 
03/24Mixed general shareholder meeting 
03/24Mixed general shareholder meeting 
Upcoming event on LONZA GROUP AG
07/22/22Interim 2022 Earnings Release
Upcoming sector events
07/26/22IQVIA HOLDINGS INC. : Interim 2022 Earnings Release (Projected)
07/28/22SEAGEN INC. : Interim 2022 Earnings Release (Projected)
08/03/22MODERNA, INC. : Interim 2022 Earnings Release (Projected)
10/26/22IQVIA HOLDINGS INC. : Q3 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research